Lo, Yi-Ching
Urgosedin inhibits hypotension, hypoglycemia, and pro-inflammatory mediators induced by lipopolysaccharide. [electronic resource]
- Journal of cardiovascular pharmacology Sep 2004
- 363-71 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
ISSN: 0160-2446
Standard No.: 10.1097/01.fjc.0000137155.63604.7a doi
Subjects--Topical Terms: Administration, Oral Adrenergic alpha-Antagonists--administration & dosage Animals Aorta, Thoracic--drug effects Benzene Derivatives--administration & dosage Blood Glucose Cell Line Cytokines--adverse effects Dose-Response Relationship, Drug Drug Evaluation, Preclinical--methods Gene Expression Regulation, Enzymologic--drug effects Heart Rate--drug effects Hypoglycemia--chemically induced Hypotension--chemically induced Inflammation Mediators--antagonists & inhibitors Injections, Intraperitoneal Injections, Intravenous Lipopolysaccharides--administration & dosage Mice Mice, Inbred ICR Muscle Contraction--drug effects Muscle, Smooth, Vascular--drug effects Nitric Oxide Synthase--antagonists & inhibitors Nitric Oxide Synthase Type II Norepinephrine--pharmacology Piperazines--administration & dosage Prodrugs--adverse effects Rats Rats, Wistar Serotonin--pharmacology Serotonin Agents--administration & dosage Toxicity Tests, Acute--methods